Vitality Watch

Dossier pubmed meta analysis 13-nov-2026
Systematic review or meta-analysis of multiple human studies

Weight, Fat Mass, and Lean Mass Changes After Bariatric Surgery and GLP-1-Based Therapy: A Systematic Review and Meta-Analysis.

Key claim: Metabolic and bariatric surgery produces greater total weight and absolute fat and lean mass loss than GLP-1-based therapies at 12 months, without clearly demonstrating poorer proportional lean mass preservation.

Abstract

Metabolic and bariatric surgery (MBS) and GLP-1-based therapies both reduce weight, but their effects on body composition are not directly comparable across measurement methods. We systematically reviewed 31 studies; 30 studies comprising 5,616 participants were included in random-effects meta-analyses stratified by dual-energy X-ray absorptiometry or bioelectrical impedance analysis, with 12 months as the primary timepoint. In both modalities, MBS was associated with greater total weight and absolute fat-mass loss than GLP-1-based therapy. Greater absolute lean-mass loss accompanied the larger weight reduction, without establishing poorer proportional lean-mass preservation. Relative fat-mass change differed by modality, and heterogeneity was substantial. These indirect subgroup comparisons should not be interpreted as head-to-head treatment effects. Standardized comparative studies incorporating muscle strength and physical function are needed.

Why this matters

This human-study meta-analysis distinguishes absolute lean-mass loss from proportional preservation: surgery produced larger absolute losses than GLP-1-based therapy at 12 months, but was not clearly worse on proportional preservation [human-observational; underlying study designs unspecified in the supplied summary]. For the AOM-as-longevity narrative, these body-composition findings establish neither preserved strength and function nor longer life, and the finding supplies no new evidence of consumer-trend growth [human-observational].

Source

Link

Briefing card

Weight, Fat Mass, and Lean Mass Changes After Bariatric Surgery and GLP-1-Based Therapy: A Systematic Review and Meta-Analysis.
Stage: meta analysis · pubmed · 13-nov-2026

If you are comparing GLP-1-based therapy with bariatric surgery, this review found greater weight, fat, and absolute lean-mass loss after surgery at 12 months, but no clear evidence of poorer proportional lean-mass preservation.

Metabolic and bariatric surgery produces greater total weight and absolute fat and lean mass loss than GLP-1-based therapies at 12 months, without clearly demonstrating poorer proportional lean mass preservation.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1007/s11695-026-09024-2

build build 880 · 2bcef25 · 2026-11-18